PATENT CLAIM ANALYSIS

Application Number: 16271150
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-05
Patent Classification: ["435", "455000"]

Abstract:
A method of generating protein-induced pluripotent stem cells by delivering bacterially expressed reprogramming proteins into nuclei of starting somatic cells using the QQ-protein transduction technique, repeating several cell reprogramming cycles for creating reprogrammed protein-induced pluripotent stem cells, moving the reprogrammed cells into a feeder-free medium for expansion, and expanding and passaging the reprogrammed cells in a whole dish for generating homogeneous piPS cells. Also provided are the piPCS cells formed using this method and uses thereof.

Claim (Index 11):
The piPSC cells according to  claim 9 , wherein said cells were derived from cells selected from the group consisting essentially of cells from different healthy animal and human somatic cells including, but not limited to, mouse primary fibroblasts, adult mouse fibroblasts, human newborn fibroblasts, human primary adult fibroblasts, human adult keratinocytes, and human amniotic fluid.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 99.0
- Lexical Diversity: 1.5283
- Patent Class: 435.0
- Transitional Phrase Type: half
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15808205', '14113522', '12939454', '12997815', '14117589']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7398530786143369
- 35 USC 102 Novelty (BERT): 0.6176567838841038
- Combined Prediction Score: 0.7276334491413137
- Mean Citation Score: 584.3899200000002
- Max Citation Score: 810.3085
- Similarity Product: 495.7603242127298

Labels:
- Claim Label 101: 0
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test